0001752724-23-123865.txt : 20230530 0001752724-23-123865.hdr.sgml : 20230530 20230530093609 ACCESSION NUMBER: 0001752724-23-123865 CONFORMED SUBMISSION TYPE: NPORT-P PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20230331 FILED AS OF DATE: 20230530 DATE AS OF CHANGE: 20230530 PERIOD START: 20231231 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LOOMIS SAYLES FUNDS II CENTRAL INDEX KEY: 0000872649 IRS NUMBER: 043113285 STATE OF INCORPORATION: MA FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: NPORT-P SEC ACT: 1940 Act SEC FILE NUMBER: 811-06241 FILM NUMBER: 23971827 BUSINESS ADDRESS: STREET 1: 888 BOYLSTON STREET STREET 2: 8TH FLOOR CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 617-449-2810 MAIL ADDRESS: STREET 1: 888 BOYLSTON STREET STREET 2: 8TH FLOOR CITY: BOSTON STATE: MA ZIP: 02199 FORMER COMPANY: FORMER CONFORMED NAME: LOOMIS SAYLES FUNDS I DATE OF NAME CHANGE: 20031119 FORMER COMPANY: FORMER CONFORMED NAME: LOOMIS SAYLES FUNDS DATE OF NAME CHANGE: 20031015 FORMER COMPANY: FORMER CONFORMED NAME: LOOMIS SAYLES FUNDS II DATE OF NAME CHANGE: 20030718 0000872649 S000070337 Loomis Sayles International Growth Fund C000223746 Class Y LIGYX C000223747 Class A LIGGX C000223748 Class C LIGCX C000223749 Class N LIGNX NPORT-P 1 primary_doc.xml NPORT-P false 0000872649 XXXXXXXX S000070337 C000223746 C000223749 C000223748 C000223747 LOOMIS SAYLES FUNDS II 811-06241 0000872649 5493007QOEDY6IHOTU14 888 BOYLSTON STREET Suite 800 BOSTON 02199-8197 617-449-2139 Loomis Sayles International Growth Fund S000070337 549300B3EC2I33ZC7N86 2023-12-31 2023-03-31 N 29176607.65 62187.26 29114420.39 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 92993.56000000 N Kweichow Moutai Co Ltd N/A Kweichow Moutai Co Ltd 000000000 4000.00000000 NS 1056453.46000000 3.628626109839 Long EC CORP CN N 2 N N N SAP SE 529900D6BF99LW9R2E68 SAP SE 000000000 6959.00000000 NS 878716.14000000 3.018147461736 Long EC CORP DE N 2 N N N Novo Nordisk A/S 549300DAQ1CVT6CXN342 Novo Nordisk A/S 000000000 10328.00000000 NS 1640305.95000000 5.633998300592 Long EC CORP DK N 2 N N N Dali Foods Group Co Ltd 52990093PPQC644N7T38 Dali Foods Group Co Ltd 000000000 571000.00000000 NS 238072.28000000 0.817712586446 Long EC CORP KY N 2 N N N Reckitt Benckiser Group PLC 5493003JFSMOJG48V108 Reckitt Benckiser Group PLC 000000000 11898.00000000 NS 905169.77000000 3.109008380983 Long EC CORP GB N 2 N N N Sodexo SA 969500LCBOG12HXPYM84 Sodexo SA 000000000 7918.00000000 NS 773355.40000000 2.656262393826 Long EC CORP FR N 2 N N N Roche Holding AG 549300U41AUUVOAAOB37 Roche Holding AG 000000000 3228.00000000 NS 922376.67000000 3.168109334289 Long EC CORP CH N 2 N N N Alibaba Group Holding Ltd 5493001NTNQJDH60PM02 Alibaba Group Holding Ltd 01609W102 4275.00000000 NS USD 436819.50000000 1.500354443429 Long EC CORP KY N 1 N N N NXP Semiconductors NV 724500M9BY5293JDF951 NXP Semiconductors NV 000000000 4526.00000000 NS USD 843985.85000000 2.898858499308 Long EC CORP NL N 1 N N N Block Inc 549300OHIIUWSTIZME52 Block Inc 852234103 8437.00000000 NS USD 579200.05000000 1.989392343180 Long EC CORP US N 1 N N N Adyen NV 724500973ODKK3IFQ447 Adyen NV 000000000 636.00000000 NS 1013420.10000000 3.480818393170 Long EC CORP NL N 2 N N N CRISPR Therapeutics AG 506700O6IRRIQLT3W370 CRISPR Therapeutics AG 000000000 8178.00000000 NS USD 369890.94000000 1.270473308570 Long EC CORP CH N 1 N N N Doximity Inc N/A Doximity Inc 26622P107 16419.00000000 NS USD 531647.22000000 1.826061494195 Long EC CORP US N 1 N N N Nestle SA KY37LUS27QQX7BB93L28 Nestle SA 000000000 8546.00000000 NS 1042018.08000000 3.579044562940 Long EC CORP CH N 2 N N N Galaxy Entertainment Group Ltd 549300ZSEBV3HR826S10 Galaxy Entertainment Group Ltd 000000000 45000.00000000 NS 301012.38000000 1.033894461808 Long EC CORP HK N 2 N N N WiseTech Global Ltd 254900VE3AF301Q85K83 WiseTech Global Ltd 000000000 41165.00000000 NS 1813468.08000000 6.228762433556 Long EC CORP AU N 2 N N N Unilever PLC 549300MKFYEKVRWML317 Unilever PLC 000000000 12142.00000000 NS 628540.72000000 2.158863929215 Long EC CORP GB N 2 N N N FANUC Corp 529900QTSW745LOKW705 FANUC Corp 000000000 30500.00000000 NS 1101421.70000000 3.783079605384 Long EC CORP JP N 2 N N N Tesla Inc 54930043XZGB27CTOV49 Tesla Inc 88160R101 4786.00000000 NS USD 992903.56000000 3.410349739749 Long EC CORP US N 1 N N N Yum China Holdings Inc 529900DO9BYZ7VA3K502 Yum China Holdings Inc 98850P109 15331.00000000 NS USD 971832.09000000 3.337975054910 Long EC CORP US N 1 N N N Anheuser-Busch InBev SA/NV 5493008H3828EMEXB082 Anheuser-Busch InBev SA/NV 000000000 10089.00000000 NS 672531.08000000 2.309958676804 Long EC CORP BE N 2 N N N Budweiser Brewing Co APAC Ltd 549300YF1MR4GTF18132 Budweiser Brewing Co APAC Ltd 000000000 70200.00000000 NS 213641.56000000 0.733799804832 Long EC CORP KY N 2 N N N Ambev SA 549300TH5Q6VRP8OT012 Ambev SA 02319V103 391016.00000000 NS USD 1102665.12000000 3.787350409966 Long EC CORP BR N 1 N N N Trip.com Group Ltd 2549004RMYDSRQL4KW41 Trip.com Group Ltd 89677Q107 30254.00000000 NS USD 1139668.18000000 3.914445710179 Long EC CORP KY N 1 N N N Experian PLC 635400RXXHHYT1JTSZ26 Experian PLC 000000000 22352.00000000 NS 736000.00000000 2.527956902940 Long EC CORP JE N 2 N N N Vipshop Holdings Ltd 549300I9F52K06HPZX60 Vipshop Holdings Ltd 92763W103 50804.00000000 NS USD 771204.72000000 2.648875401499 Long EC CORP KY N 1 N N N Baidu Inc 254900AL64IANZYI1E02 Baidu Inc 056752108 5227.00000000 NS USD 788858.84000000 2.709512432096 Long EC CORP KY N 1 N N N Unicharm Corp 353800UQ4BZIJTAQEG85 Unicharm Corp 000000000 6500.00000000 NS 267187.22000000 0.917714371163 Long EC CORP JP N 2 N N N Shopify Inc 549300HGQ43STJLLP808 Shopify Inc 82509L107 13535.00000000 NS USD 648867.90000000 2.228682183289 Long EC CORP CA N 1 N N N Diageo PLC 213800ZVIELEA55JMJ32 Diageo PLC 000000000 8093.00000000 NS 361187.55000000 1.240579565595 Long EC CORP GB N 2 N N N EssilorLuxottica SA 549300M3VH1A3ER1TB49 EssilorLuxottica SA 000000000 3109.00000000 NS 560623.48000000 1.925586951380 Long EC CORP FR N 2 N N N MercadoLibre Inc 549300DKPDN9M5S8GB14 MercadoLibre Inc 58733R102 1328.00000000 NS USD 1750383.68000000 6.012084927513 Long EC CORP US N 1 N N N Novartis AG 5493007HIVTX6SY6XD66 Novartis AG 000000000 9632.00000000 NS 884395.97000000 3.037656110453 Long EC CORP CH N 2 N N N Tencent Holdings Ltd 254900N4SLUMW4XUYY11 Tencent Holdings Ltd 000000000 30300.00000000 NS 1480739.61000000 5.085931954560 Long EC CORP KY N 2 N N N Fixed Income Clearing Corp 549300H47WTHXPU08X20 FIXED INC CLEARING CORP.REPO 000000000 568346.47000000 PA USD 568346.47000000 1.952113290894 Long RA CORP US N 2 Repurchase N 2.10000000 2023-04-03 594700.00000000 USD 579762.92000000 USD UST N N N 2023-04-28 LOOMIS SAYLES FUNDS II John Sgroi John Sgroi Assistant Treasurer XXXX NPORT-EX 2 NPORT_48AR_85644835_0323.htm HTML

PORTFOLIO OF INVESTMENTS – as of March 31, 2023 (Unaudited)

Loomis Sayles International Growth Fund

 

Shares     

Description

   Value (†)  
               
 

Common Stocks – 97.6% of Net Assets

 
   Australia – 6.2%

 

  41,165     

WiseTech Global Ltd.

   $ 1,813,468  
     

 

 

 
   Belgium – 2.3%

 

  10,089     

Anheuser-Busch InBev SA

     672,531  
     

 

 

 
   Brazil – 9.8%

 

      391,016     

Ambev SA, ADR

     1,102,665  
  1,328     

MercadoLibre, Inc.(a)

     1,750,384  
     

 

 

 
        2,853,049  
     

 

 

 
   Canada – 2.2%

 

  13,535     

Shopify, Inc., Class A(a)

     648,868  
     

 

 

 
   China – 27.3%

 

  4,275     

Alibaba Group Holding Ltd., ADR(a)(b)

     436,819  
  5,227     

Baidu, Inc., ADR(a)(b)

     788,859  
  70,200     

Budweiser Brewing Co. APAC Ltd., 144A

     213,642  
  571,000     

Dali Foods Group Co. Ltd., 144A

     238,072  
  4,000     

Kweichow Moutai Co. Ltd., Class A

     1,056,453  
  4,526     

NXP Semiconductors NV

     843,986  
  30,300     

Tencent Holdings Ltd.(b)

     1,480,740  
  30,254     

Trip.com Group Ltd., ADR(a)(b)

     1,139,668  
  50,804     

Vipshop Holdings Ltd., ADR(a)(b)

     771,205  
  15,331     

Yum China Holdings, Inc.

     971,832  
     

 

 

 
        7,941,276  
     

 

 

 
   Denmark – 5.7%

 

  10,328     

Novo Nordisk AS, Class B

     1,640,306  
     

 

 

 
   France – 4.6%

 

  3,109     

EssilorLuxottica SA

     560,624  
  7,918     

Sodexo SA

     773,355  
     

 

 

 
        1,333,979  
     

 

 

 
   Germany – 3.0%

 

  6,959     

SAP SE

     878,716  
     

 

 

 
   Japan – 4.7%

 

  30,500     

FANUC Corp.

     1,101,422  
  6,500     

Unicharm Corp.

     267,187  
     

 

 

 
            1,368,609  
     

 

 

 
   Macau – 1.0%

 

  45,000     

Galaxy Entertainment Group Ltd.(a)

     301,012  
     

 

 

 
   Netherlands – 3.5%

 

  636     

Adyen NV, 144A(a)

     1,013,420  
     

 

 

 
   Switzerland – 4.3%

 

  8,178     

CRISPR Therapeutics AG(a)

     369,891  


Shares     

Description

   Value (†)  
               
 

Common Stocks – continued

 
   Switzerland – continued

 

  9,632     

Novartis AG, (Registered)

   $ 884,396  
     

 

 

 
            1,254,287  
     

 

 

 
   United Kingdom – 6.5%

 

  8,093     

Diageo PLC

     361,187  
  11,898     

Reckitt Benckiser Group PLC

     905,170  
  12,142     

Unilever PLC

     628,541  
     

 

 

 
            1,894,898  
     

 

 

 
   United States – 16.5%

 

  8,437     

Block, Inc.(a)

     579,200  
  16,419     

Doximity, Inc., Class A(a)

     531,647  
  22,352     

Experian PLC

     736,000  
  8,546     

Nestle SA, (Registered)

     1,042,018  
  3,228     

Roche Holding AG

     922,377  
  4,786     

Tesla, Inc.(a)

     992,904  
     

 

 

 
            4,804,146  
     

 

 

 
  

Total Common Stocks
(Identified Cost $30,387,391)

     28,418,565  
     

 

 

 
Principal
Amount
             
               
 

Short-Term Investments – 2.0%

 
  $    568,346      Tri-Party Repurchase Agreement with Fixed Income Clearing Corporation, dated 3/31/2023 at 2.100% to be repurchased at $568,446 on 4/03/2023 collateralized by $594,700 U.S. Treasury Note, 2.875% due 6/15/2025 valued at $579,763 including accrued interest(c)
(Identified Cost $568,346)
     568,346  
     

 

 

 
   Total Investments – 99.6%
(Identified Cost $30,955,737)
         28,986,911  
   Other assets less liabilities – 0.4%      127,509  
     

 

 

 
   Net Assets – 100.0%    $ 29,114,420  
     

 

 

 


(†)
  

Registered investment companies are required to value portfolio investments using an unadjusted, readily available market quotation. The Fund obtains readily available market quotations from independent pricing services. Fund investments for which readily available market quotations are not available are priced at fair value pursuant to the Fund’s Valuation Procedures. The Board of Trustees has approved a valuation designee who is subject to the Board’s oversight.

   Unadjusted readily available market quotations that are utilized for exchange traded equity securities (including shares of closed-end investment companies and exchange-traded funds) include the last sale price quoted on the exchange where the security is traded most extensively. Shares of open-end investment companies are valued at net asset value per share.
   Exchange traded equity securities for which there is no reported sale during the day are fair valued at the closing bid quotation as reported by an independent pricing service. Unlisted equity securities (except unlisted preferred equity securities) are fair valued at the last sale price quoted in the market where they are traded most extensively or, if there is no reported sale during the day, the closing bid quotation as reported by an independent pricing service. If there is no last sale price or closing bid quotation available, unlisted equity securities will be fair valued using evaluated bids furnished by an independent pricing service, if available.
   Debt securities and unlisted preferred equity securities are fair valued based on evaluated bids furnished to the Fund by an independent pricing service or bid prices obtained from broker-dealers. Broker-dealer bid prices may be used to fair value debt and unlisted equities where an independent pricing service is unable to price an investment or where an independent pricing service does not provide a reliable price for the investment.
   The Fund may also fair value investments in other circumstances such as when extraordinary events occur after the close of a foreign market, but prior to the close of the New York Stock Exchange. This may include situations relating to a single issuer (such as a declaration of bankruptcy or a delisting of the issuer’s security from the primary market on which it has traded) as well as events affecting the securities markets in general (such as market disruptions or closings and significant fluctuations in U.S. and/or foreign markets). When fair valuing a Fund’s investments, the valuation designee may, among other things, use modeling tools or other processes that may take into account factors such as issuer specific information, or other related market activity and/or information that occurred after the close of the foreign market but before the time the Fund’s net asset value (“NAV”) is calculated. Fair valuation by the Fund’s valuation designee may require subjective determinations about the value of the investment, and fair values used to determine a Fund’s NAV may differ from quoted or published prices, or from prices that are used by others, for the same investments. In addition, the use of fair value pricing may not always result in adjustments to the prices of investments held by a Fund.
   The books and records of the Fund are maintained in U.S. dollars. The values of securities, currencies and other assets and liabilities denominated in currencies other than U.S. dollars are translated into U.S. dollars based upon foreign exchange rates prevailing at the end of the period.
(a)    Non-income producing security.
(b)   

Security invests in variable interest entities based in China.

(c)
   The Fund may enter into repurchase agreements, under the terms of a Master Repurchase Agreement, under which the Fund acquires securities as collateral and agrees to resell the securities at an agreed upon time and at an agreed upon price. It is the Fund’s policy that the market value of the collateral for repurchase agreements be at least equal to 102% of the repurchase price, including interest. Certain repurchase agreements are tri-party arrangements whereby the collateral is held in a segregated account for the benefit of the Fund and on behalf of the counterparty. Repurchase agreements could involve certain risks in the event of default or insolvency of the counterparty, including possible delays or restrictions upon the Fund’s ability to dispose of the underlying securities. As of March 31, 2023, the Fund had an investment in a repurchase agreement for which the value of the related collateral exceeded the value of the repurchase agreement.
144A
   All or a portion of these securities are exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers. At March 31, 2023, the value of Rule 144A holdings amounted to $1,465,134 or 5.0% of net assets.
ADR
   An American Depositary Receipt is a certificate issued by a custodian bank representing the right to receive securities of the foreign issuer described. The values of ADRs may be significantly influenced by trading on exchanges not located in the United States.


Fair Value Measurements

In accordance with accounting standards related to fair value measurements and disclosures, the Fund has categorized the inputs utilized in determining the value of the Fund’s assets or liabilities. These inputs are summarized in the three broad levels listed below:

 

   

Level 1 — quoted prices in active markets for identical assets or liabilities;

 

   

Level 2 — prices determined using other significant inputs that are observable either directly, or indirectly through corroboration with observable market data (which could include quoted prices for similar assets or liabilities, interest rates, credit risk, etc.); and

 

   

Level 3 — prices determined using significant unobservable inputs when quoted prices or observable inputs are unavailable such as when there is little or no market activity for an asset or liability (unobservable inputs reflect the Fund’s own assumptions in determining the fair value of assets or liabilities and would be based on the best information available).

The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.

The Fund’s pricing policies have been approved by the Board of Trustees. Investments for which market quotations are readily available are categorized in Level 1. Other investments for which an independent pricing service is utilized are categorized in Level 2. Broker-dealer bid prices for which the Fund has knowledge of the inputs used by the broker-dealer are categorized in Level 2. All other investments, including broker-dealer bid prices for which the Fund does not have knowledge of the inputs used by the broker-dealer, as well as investments fair valued by the valuation designee, are categorized in Level 3. All Level 2 and 3 securities are defined as being fair valued.

Under certain conditions and based upon specific facts and circumstances, the Fund’s valuation designee may determine that a fair valuation should be made for portfolio investment(s). These valuation designee fair valuations will be based upon a significant amount of Level 3 inputs.


The following is a summary of the inputs used to value the Fund’s investments as of March 31, 2023, at value:

Asset Valuation Inputs

 

Description

   Level 1      Level 2      Level 3      Total  

Common Stocks

           

Australia

   $ —        $ 1,813,468      $
—  
 
   $ 1,813,468  

Belgium

     —          672,531        —          672,531  

China

     4,952,369        2,988,907        —          7,941,276  

Denmark

     —          1,640,306        —          1,640,306  

France

     —          1,333,979        —          1,333,979  

Germany

     —          878,716        —          878,716  

Japan

     —          1,368,609        —          1,368,609  

Macau

     —          301,012        —          301,012  

Netherlands

     —          1,013,420        —          1,013,420  

Switzerland

     369,891        884,396        —          1,254,287  

United Kingdom

     —          1,894,898        —          1,894,898  

United States

     2,103,751        2,700,395        —          4,804,146  

All Other Common Stocks*

     3,501,917               —          3,501,917  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total Common Stocks

     10,927,928        17,490,637        —          28,418,565  
  

 

 

    

 

 

    

 

 

    

 

 

 

Short-Term Investments

     —          568,346        —          568,346  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 10,927,928      $ 18,058,983      $ —        $ 28,986,911  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

*

Details of the major categories of the Fund’s investments are reflected within the Portfolio of Investments.


Industry Summary at March 31, 2023 (Unaudited)

 

Pharmaceuticals

     11.9

Beverages

     11.6  

Hotels, Restaurants & Leisure

     11.0  

Broadline Retail

     10.2  

Software

     9.2  

Interactive Media & Services

     7.8  

Financial Services

     5.5  

Food Products

     4.4  

Household Products

     4.0  

Machinery

     3.8  

Automobiles

     3.4  

Semiconductors & Semiconductor Equipment

     2.9  

Professional Services

     2.5  

IT Services

     2.2  

Personal Care Products

     2.2  

Other Investments, less than 2% each

     5.0  

Short-Term Investments

     2.0  
  

 

 

 

Total Investments

     99.6  

Other assets less liabilities

     0.4  
  

 

 

 

Net Assets

     100.0
  

 

 

 


Currency Exposure Summary at March 31, 2023 (Unaudited)

 

United States Dollar

     39.6

Euro

     15.6  

Swiss Franc

     9.8  

Hong Kong Dollar

     7.6  

British Pound

     6.8  

Australian Dollar

     6.2  

Danish Krone

     5.7  

Japanese Yen

     4.7  

Yuan Renminbi

     3.6  
  

 

 

 

Total Investments

     99.6  

Other assets less liabilities

     0.4  
  

 

 

 

Net Assets

     100.0